DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "BRIC Diabetes Care Devices Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
Diabetes care devices helps in the management of blood glucose levels caused in patients due to inadequate insulin production or insulin resistance. The Diabetes Care Devices Market in Brazil, Russia, India and China (BRIC) nations is largely driven by the increasing incidence of diabetics across BRIC countries, especially among obese population, increased R&D activities on diabetes, along with increasing collaborations and funding to support diabetes research. However, exorbitant cost of availing diabetes care devices, irregular reimbursement, presence of cost-effective alternative treatments, and lack of diabetic care awareness may hinder the growth of the market.
Large untapped market has great potential for the growth of diabetes care devices coupled with favorable government policies are factors that create growth opportunities in this market. Pricing pressure faced by global players is a key market challenge.
The report segments BRIC diabetes care devices market on the basis of types and country. Based on type, the market is segmented into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring devices is segmented into testing strips, self-monitoring blood glucose meters, lancets, continuous glucose monitors and others. The insulin delivery devices are further segmented into insulin syringes, insulin pens, insulin pumps and insulin jet injectors. On the basis of country, the market is segmented into Brazil, Russia, China, and India.
Key Market Segments
Blood Glucose Monitoring Devices
- Testing Strips
- Self-monitoring Blood Glucose Meters
- Lancets
- Continuous Glucose Monitors
-
Others
Insulin Delivery Devices
- Insulin Syringes
- Insulin Pens
- Insulin Pumps
-
Insulin Jet Injectors
By Country
- Brazil
- Russia
- China
-
India
Prominent Market Player
- Becton, Dickinson and Company (U.S.)
- Roche Diagnostics Ltd. (Switzerland)
- Johnson and Johnson (U.S.)
- Bayer AG (Germany)
- Abbott Laboratories (U.S.)
- Acon Laboratories, Inc. (U.S.)
- Ypsomed AG (Switzerland)
- Novo Nordisk A/S (Denmark)
- Medtronic Plc. (Ireland)
- ARKRAY Inc. (Japan)
- Terumo Corporation (Japan)
- Dexcom, Inc. (U.S.)
-
Sanofi (France).
For more information about this report visit http://www.researchandmarkets.com/research/gx46tb/bric_diabetes
